Mitchell S.V. Elkind, MD, MS, MPhil
- Professor of Neurology and Epidemiology (in the Gertrude H. Sergievsky Center)
Dr. Mitchell Elkind is a Professor of Neurology at Columbia University College of Physicians and Surgeons in New York City and an Attending Neurologist on the Stroke Service at the NewYork-Presbyterian Hospital. He is also the past Director of the Neurology Residency Training Program. Dr. Elkind received his undergraduate degree from Harvard College and a master's degree in the History and Philosophy of Science from Cambridge University in England. After receiving his medical degree in 1992 from Harvard Medical School, he trained in internal medicine at Brigham and Women's Hospital in Boston, and in neurology at the Massachusetts General Hospital, where he was Chief Resident 1995-6. He completed his master's degree in epidemiology at the Columbia University School of Public Health in 1998, as well as fellowship training in cerebrovascular diseases working with Drs. Ralph Sacco and J. P. Mohr.
Dr. Elkind is a co-investigator in the Northern Manhattan Stroke Study, and is the recipient of grants from the American Heart Association (AHA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH) to study the relationship between infection, inflammation and stroke. He has participated in several clinical trials of acute and preventive stroke therapy, and has lectured extensively on cerebrovascular disease. His clinical work is directed toward the care of patients with stroke.
He is the author of a medical student board review text on neurology. He is a member of the American Heart Association, National Stroke Association, and American Academy of Neurology.
Research focuses on different inflammatory markers and infections, such as C. pneumoniae and periodontal disease, as potential causes of atherosclerosis and ischemic stroke; se of high-resolution duplex doppler ultrasonography as a measure of stroke risk; amd clinical trials of neuroprotectants and surgical hemicraniectomy for acute stroke, and antiplatelet and of other therapies for stroke prevention.
Departmental Appointments
- Department of Neurology
Division of Stroke and Cerebrovascular Disease - Department of Epidemiology
Board Certifications
- Vascular Neurology
- Neurology
Areas of Expertise
- Cerebrovascular Disease
- Stroke
Education & Training
- Harvard Medical School
- Internship: Brigham & Women's Hospital - Harvard
- Residency: Massachusetts General Hospital
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Locations
Neurological Institute of New York
710 West 168th Street
New York, NY 10032- Phone:
- (212) 305-1710
- For new and current patient appointments, call:
- (212) 305-1710
- Fax:
- (212) 305-1658
Centers/Institutes/Programs
- Gertrude H. Sergievsky Center
Provider Affiliations
- NewYork-Presbyterian/Columbia
Insurance Programs
Please contact the provider's office directly to verify that your particular insurance is accepted.
- Aetna [EPO, HMO, Medicare Managed Care, NY Signature, POS, PPO, Signature Administrators, Student Health]
- Affinity [Essential Plan, Medicaid Managed Care, Medicare Managed Care]
- Amida Care [Special Needs Plan]
- Cigna [EPO, Great West, HMO, POS, PPO]
- Emblem/GHI [HMO, Medicare Managed Care, PPO]
- Empire Blue Cross Blue Shield [Blue Priority, EPO, HMO, Medicare (Mediblue), NYP Employee Plan, Pathway (Exchange), POS, PPO]
- Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
- Fidelis Care [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
- Healthfirst [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
- Local 1199 [Local 1199]
- MagnaCare [MagnaCare]
- Oxford Health Plans [Freedom, Liberty, Medicare Managed Care]
- UnitedHealthcare [Columbia University Employee Plan, EPO, Essential Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]
- VNSNY CHOICE [Medicare Managed Care, SelectHealth]
- WellCare [Medicaid Managed Care, Medicare Managed Care]
This provider accepts new patients
Appointment Phone Number: (212) 305-1710
Links
Research Interests
- Relationship between infection, inflammation and stroke
NIH Grants
POOR SLEEP, SEDENTARY BEHAVIOR, AND SECONDARY CARDIOVASCULAR RISK IN STROKE AND TIA PATIENTS (Federal Gov)
May 4 2018 - Mar 31 2023
SERVICE AGREEMENT - RELATED TO COST EFFECTIVENESS MODEL (P&S Industry Clinical Trial)
Jan 18 2018 - Jan 18 2023
ATRIAL CARDIOPATHRY AND ANTITHROMBOTIC DRUGS IN PREVENTION AFTER CRY[TOGENIC STROKE(ARCADIA)/RD 003152 (P&S Industry Clinical Trial)
Aug 2 2017 - Aug 2 2022
REVEAL AF 2017 SERVICE AGREEMENT (P&S Industry Clinical Trial)
Jul 20 2017 - Jul 20 2022
THE EFFECT OF LOWER PRESSURE OVER THE LIFE COURSE ON LATE-LIFE COGNITION IN BLACK (Federal Gov)
Aug 1 2017 - May 31 2022
ATRIAL CARDIOPATHY AND ANTITHROMBOTIC DRUGS IN PREVENTION AFTER CRYPTOGENIC STROKE (ARCADIA) (Federal Gov)
May 1 2017 - Apr 30 2022
CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)
Jul 1 2016 - May 31 2021
IMPACT OF PTSD ON CARDIOVASCULAR RISK IN SURVIVORS OF STROKE AND TRANSIENT ISCHEMIC ATTACK (Federal Gov)
Jun 20 2016 - Mar 31 2020
PREVALENCE AND PREDICTORS OF ASYMPTOMATIC ATRIAL FIBRILLATION IN THE COMMUNITY (Federal Gov)
Apr 1 2014 - Jan 31 2020
RACIAL DISPARITIES, INFLUENZA LIKE ILLNESS AND THE ASSOCIATION BETWEEN SHORT-TERM EXPOSURE TO AMBIENT AIR POLLUTION AND CARDIOVASCULAR OUTCOMES (Federal Gov)
Sep 24 2017 - Jun 30 2019
NEUROEPIDEMIOLOGY TRAINING PROGRAM (Federal Gov)
Jul 1 2014 - Jun 30 2019
COLUMBIA GENIE (GENOMIC INTEGRATION WITH EHR) (Federal Gov)
Sep 1 2015 - May 31 2019
BIOGEN IDEC SCIENTIFIC LEADER ACTIVITIES ON PROTOCOL 101SK201. A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF IV NATALIZUMAB (BG00002) (P&S Industry Clinical Trial)
Aug 26 2013 - Aug 26 2018
THE TRAJECTORY OF FUNCTIONAL STATUS AND QUALITY OF LIFE BEFORE AND AFTER STROKE (Federal Gov)
Apr 1 2013 - Mar 31 2018
TRIAGE AND OUTPATIENT EVALUATION OF PATIENTS WITH TIA AND MINOR STROKE THE RAPID ACCESS VASCULAR EVALUATION-NEUROLOGY (RAVEN) APPROACH (NY State Gov)
Dec 31 2015 - Dec 30 2017
NEW YORK COLUMBIA COLLABORATIVE SPOTRIAS (Federal Gov)
Aug 1 2010 - Jul 31 2016
COMPARATIVE EFFECTIVENESS ANALYSIS OF TREAT-TO-TARGET AND RISK-BASED BLOOD PRESSURE CONTROL GUIDELINES (Federal Gov)
Aug 19 2011 - Jun 30 2016
PHYSICAL ACTIVITY PATTERNS VIA NEW DIMENSION-INFORMATIVE CLUSTER MODELS (CHEUNG/ELKIND) (Federal Gov)
Aug 17 2012 - Apr 30 2016
FGF-23 AND PHOSPHORUS IN STROKE, SUBCLINICAL VASCULAR DAMAGE, AND COGNITION (Federal Gov)
Mar 16 2012 - Feb 28 2016
STROKE INCIDENCE AND RISK FACTORS IN A TRI-ETHNIC REGION (Federal Gov)
Sep 30 2015 - Dec 31 2015
MINORITIES WITH ICH (Federal Gov)
Jul 1 2010 - Jul 31 2015
MINORITIES WITH ICH (Federal Gov)
Jul 1 2010 - Jun 30 2015
STROKE INCIDENCE AND RISK FACTORS IN A TRI-ETHNIC REGION (Federal Gov)
Apr 1 2008 - Mar 31 2015
MECHANISMS OF EARLY RECURRENCE IN INTRACRANIAL ATHEROSCLEROTIC DISEASE (Federal Gov)
Mar 1 2014 - Feb 28 2015
VASCULAR EFFECTS OF INFECTION IN PEDIATRIC STROKE (Federal Gov)
Aug 5 2009 - Jul 31 2014
MODIFIABLE RISK FACTORS IN STROKE INCIDENCE AND MORTALITY AMONG WOMEN (Federal Gov)
Jul 1 2011 - Jun 30 2014
THE VERTEBROBASILAR FLOW EVALUATION AND RISK OF TRANSIENT ISCHEMIC ATTACK & STROKE (VERITAS) STUDY (Federal Gov)
Jul 1 2009 - Jun 30 2014
VASCULAR EFFECTS OF INFECTION IN PEDIATRIC STROKE (Federal Gov)
Aug 5 2009 - Jul 31 2013
DOSE AND TREATMENT SELECTION IN CLINICAL TRIALS (Federal Gov)
Jul 8 2006 - Jun 30 2013
THE ROLE OF COPETIN, MIDREGIONAL NATRIURETIC PEPTIDE AND PROCALCITONIN AS MARKERS OF ISCHEMIC STROKE RISK IN THE NORTHERN MANHATTAN STUDY (Private)
Jan 1 2012 - May 31 2013
STENTING VS AGGRESSIVE MEDICAL MANAGEMENT FOR PREVENTING RECURRENT EVENTS IN INTRACRANIAL STENOSIS (SAMMPRIS) (Federal Gov)
May 1 2008 - Apr 30 2013
STROKE INCIDENCE AND RISK FACTORS IN A TRI-ETHNIC REGION (Federal Gov)
Apr 1 2008 - Mar 31 2013
USE OF A MENTORED PEER REVIEW PROGRAM TO ENHANCE NEUROLOGY R ESIDENT EDUCATION ON THE BASIC CONCEPTS OF BIOSTATISTICS, RE (Private)
Jan 1 2012 - Dec 31 2012
LEVELS OF INFLAMMATORY MARKERS IN THE TREATMENT OF STROKE (LIMITS) (P&S Industry Clinical Trial)
May 18 2004 - Aug 17 2012
SECONDARY PREVENTION OF SMALL SUBCORTICAL STOKES (Federal Gov)
Dec 1 2009 - Jul 31 2012
VASCULAR EFFECTS OF INFECTION IN PEDIATRIC STROKE (Federal Gov)
Aug 5 2009 - Jul 31 2012
VIPS: VASCULAR EFFECTS OF INFECTION IN PEDIATRICS STROKE (Federal Gov)
Aug 5 2009 - Jul 31 2012
LP-PLA2 AND RISK OF STROKE IN A PROSPECTIVE COHORT STUDY IN A MULTI-ETHNIC POPULATION (Private)
Jan 13 2010 - Jan 12 2012
SECONDARY PREVENTION OF SMALL SUB-CORTICAL STROKES - (SPS3) (Federal Gov)
Feb 8 2008 - Jun 30 2011
NMT MEDICAL--G980031 (P&S Industry Clinical Trial)
Aug 9 2007 - Jun 30 2011
LEVELS OF INFLAMMATORY MARKERS IN TREATMENT OF STROKE (Federal Gov)
May 25 2005 - Apr 30 2011
INFLAMMATORY AND INFECTIOUS BURDEN AND RISK OF STROKE (Federal Gov)
Mar 1 2004 - Feb 28 2011
INFLAMMATION, LEUKOCYTE ACTIVATION, AND STROKE RISK (Private)
Jul 1 2003 - Jun 30 2007
ORAL INFECTIONS, CAROTID ATHEROSCLEROSIS AND STROKE (Federal Gov)
Jun 15 2000 - Mar 24 2006
